Letrozole

Letrozole

Strength: 2,5 mg
Quantity: 50 tablets
Active substance: letrozole 2,5 mg
Manufacturer: Magnus Pharmaceuticals

Letrozole: Precision in Hormonal Therapy

Letrozole is a potent aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. By effectively reducing estrogen levels in the body, Letrozole slows or stops the growth of certain types of breast tumors that require estrogen to thrive.

Key Benefits:

• Effective Treatment: Letrozole is clinically proven to reduce the risk of cancer recurrence, making it a vital component of adjuvant therapy following surgery.
• Targeted Action: Its targeted mechanism of action specifically inhibits aromatase, leading to a significant decrease in circulating estrogen levels.
• Well-Tolerated: Patients generally report a manageable side effect profile, allowing for adherence to treatment protocols.

Indications: Letrozole is indicated for postmenopausal women with early-stage or metastatic breast cancer. It may also be used as a first-line treatment or following tamoxifen therapy.

Administration: Letrozole is taken orally, typically in a daily dosage as prescribed by a healthcare provider.

Safety Information: As with any medication, it is essential to discuss potential side effects and interactions with your healthcare professional to ensure optimal treatment outcomes.

Choose Letrozole for a reliable approach to managing hormone-sensitive breast cancer, and empower your journey toward better health.